Enter your login e-mail to the account
Search
- INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - Metabolic changes after bariatric surgery
MUDr. Pavol Holéczy, CSc., Mgr. Marek Bužga, PhD.
(2/2016, Topic of the year ) - New possibilities of treatment of type 2 diabetes mellitus
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(3-4/2014, Review articles ) - Pulmonary fibrosis – diffuse parenchymal lung diseases
MUDr. Bohumil Matula
(1/2010, Review articles ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - Diabesity, an increasing medical problem – diabetologist must be therefore also an obesitologist
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Mesárošová, PhD.
(4/2016, Topic of the year )
- DIABETES MELLITUS TYPE 2 TREATMENT – ORAL ANTIDIABETIC AGENTS
MUDr. Pavlína Piťhová
(2/2007, clearly )
- Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Nové liečivá v EÚ registrované v roku 2013 (I.)
PharmDr. Peter Stanko
(4/2013, New drugs )